As a severe lethal cancer, hepatocellular carcinoma (HCC) usually originates from chronic liver injury and inflammation, in which the discovery of key genes is important for HCC prevention. Here, we analyzed the time serial (from 0 week to 30 weeks) transcriptome data of liver injury samples in diethylnitrosamine (DEN)-induced HCC mouse model. Through expression and function analyses, we identified that Cyp2c29 was a key gene continuously downregulated during liver injury. Overexpression of Cyp2c29 suppressed the NF-κB activation, proinflammatory cytokine production and hepatocyte proliferation by increasing its production 14,15-epoxyeicosatrienoic acid (14,15-EET). Furthermore, in vivo Cyp2c29 protected against liver inflammation in liver injury mice models by reversing the expression on functions of cell proliferation, metabolism and inflammation including suppressing NF-κB pathway and compensatory proliferation.
Introduction
Hepatocellular carcinoma (HCC) is the sixth most frequently diagnosed cancer and the second most common cause of cancer-related death worldwide (Ferlay et al, et al; Colombo & Maisonneuve et al) . Although the pathophysiology of HCC is not clearly understood, it is well known that HCC typically occurs in chronically injured and inflamed livers. Persistent injury is characterized by inflammatory cell infiltration accompanied by cytokine production (He&Karin, 2011; Balkwill&Mantovani, 2001) .
Chronic inflammation triggers compensatory cell proliferation and causes genetic mutations that may induce carcinogenesis (Ray, 2018) . The identification of key molecules and mechanisms from the liver injury to HCC will be important for HCC prevention and diagnosis.
Many inflammation-related genes in mouse are strongly correlated with their orthologous genes in patients with liver diseases (Tacke & Zimmermann, 2014) . CYP enzymes are xenobiotic-metabolizing enzymes that are primarily found in liver cells of rodents and humans (Li et al, 2017; Yu et al, 2015; Nebert & Dalton, 2006) . These enzymes are involved in eicosanoid metabolism and regulate a diverse set of homeostatic and inflammatory processes. The expression levels of CYP genes are closely associated with the progression of liver diseases. For example, Cyp2c29, Cyp2c50, Cyp2c55 and Cyp2j5 transcription levels have been found to be suppressed in a mouse model of nonalcoholic steatohepatitis (Schuck et al, 2014) . In addition, decreased expression of CYP genes, such as CYP2C8, CYP2C9, and CYP2C19, has been observed in HCC patients (Tsunedomi et al, 2005; Xu et al, 2001; Wang et al, 2018) . However, the role of CYP genes in the progression of HCC is not well characterized.
High-throughput sequencing combined with bioinformatics analysis provides a systematic way to explore crucial genes and mechanisms in complex diseases (Zhou et al, 2018) . Previously, we investigated miRNA and transcription factor (TF) coregulatory networks to reveal regulators in blood diseases Ye et al, 2012) . Our findings indicated that complex regulatory relationships involved in disease progression can be illuminated by transcriptome and network analysis.
In the present study, we detected differentially expressed genes (DEGs) during the progression of liver injury using time series gene expression analysis. We focused on Cyp2c29, which was found to be significantly downregulated in a mouse model of liver injury. Our results demonstrated that Cyp2c29 may serve as a new biomarker for the prevention, diagnosis and prognosis of HCC.
Results

Transcriptome changes during the liver injury of DEN-induced mouse model
To mimic the process of hepatocarcinogenesis, low doses of DEN and high-fat diets (HFD) were used to establish a mouse model of liver injury. Liver tissues were collected at week 0, week 10, week 20, week 25, and week 30 (w0, w10, w20, w25 and w30), respectively. Mice showed body weight loss, hepatocyte necrosis and inflammatory infiltration from w10 onwards when given DEN and fed with HFD ( Fig   5 / 43 1A, B). At w25, severe liver fibrosis was detected in the DEN treatment group, which was confirmed by observation of extensive collagen deposition and bridges between vessels upon Masson trichrome staining ( Fig 1C) . At w30, tumors were observed in 5 out of 6 mice in the DEN treatment group. In addition, hematoxylin and eosin (H&E) staining of tumor tissues showed a typical trabecular growth pattern ( Fig 1B) .
To identify key regulators in HCC progression, liver samples were collected at five time points with three replicates for each time point, and RNA-seq was performed ( Fig 1A) . From all samples, we obtained a total of 16,195 expressed genes (fragments per kilobase of transcript per million mapped reads (FPKM)>0). Genes with FPKM values >20 (approximately 10% of the genes) were considered as highly expressed genes. The five groups shared 403 highly expressed genes ( Fig EV1A) , which were mainly involved in metabolic processes of carboxylic acid, protein and triglyceride, and acute inflammatory response ( Fig EV1B) .
Gene expression was analyzed to identify key regulators, and 564 DEGs were identified through comparisons between every two adjacent time points ( Fig 1D) .
Functional enrichment analysis revealed that most of the DEGs in the w10 vs w0 comparison were enriched in drug metabolism, retinol metabolism, and oxidation reduction ( Fig 1E) , indicating metabolic dysfunction in the liver, while DEGs in the w20 vs w10 comparison were mainly enriched in lipid metabolic and biosynthetic pathways, such as cholesterol and steroid. The prominent processes associated with DEGs in the w25 vs w20 comparison were complement activation and inflammatory responses ( Fig 1E) . Next, we examined the key genes involved in the most significant 6 / 43 pathways for each comparison. Through gene-pathway crosstalk analysis, we found that CYP family genes acted as important nodes connecting multiple pathways, including drug metabolism, oxidation reduction, arachidonic acid metabolism and retinol metabolism pathways ( Fig 1F) . The importance of CYP genes in these pathways has been investigated previously in several studies (Polonikov et al, 2017; Ross & Zolfaghari, 2011; Danielson, 2002) , and our finding was consistent with the published results.
Transcriptome analysis and expression validation confirmed Cyp2c29 as a potential key gene consistently downregulated in HCC development
To further analyze the key gene(s) involved in HCC progression, we screened all 52 CYP genes detected in at least one time point that met a threshold of FPKM > 5.0 ( Fig 2A) . Approximately half of the CYP genes were continuously downregulated from w0 to w30. This finding is highly relevant to reported findings that P450 genes are downregulated during the inflammatory response (Tsunedomi et al, 2005; Xu et al, 2001; Wang et al, 2018 ). Most of the downregulated genes belong to the Cyp2b and Cyp2c subfamilies. Among the identified genes, Cyp2c29 was highly expressed at w0 but decreased during the liver injury progression (fold change (FC) = -2.88 from w0 to w10, FC = -3.02 from w10 to w20).
In addition, we performed partial least squares discriminant analysis (PLS-DA) of all the genes to identify key genes at each time point. A total of 419 marker genes 7 / 43 were obtained with variable importance in projection (VIP) scores >2.0 that contributed to distinguishing among the five groups ( Fig 2B) . Furthermore, the DEGs with VIP scores in the top 10% were determined ( Fig 2C) , and Cyp2c29 was again identified as a core gene. The reduced expression of the Cyp2c29 gene during liver injury was further confirmed by qRT-PCR analysis (n=6) ( Fig 2D) . The expression of Cyp2c29 was lower in the DEN-treated group than that in the control group at the same time point. Hepatocytes constitute about 60-80% of the total cell population in the liver (Racanelli, 2006) . We isolated different cells in the liver and found that the expression of the Cyp2c29 was mainly reduced in the hepatocytes of injured liver induced by DEN (24 h after 100 mg/kg intraperitoneally injection) ( Fig 2E) .
Cyp2c29 suppressed NF-κB activation and inflammation-stimulated cell proliferation
As a member of the Cyp2c family, Cyp2c29 is an endothelial epoxyeicosatrienoic acid (EET) synthase (Sun et al, 2010) . EETs have anti-inflammatory activity and limit damage to blood vessels caused by inflammation (Tacconelli & Patrignani, 2014) . In this study, to investigate the EET's role in HCC development, we evaluate the effects of EET on hepatocytes under an inflamed environment. To clarify the influence of inflammatory mediators, RAW264.7 cells were treated with lipopolysaccharide (LPS) to mimic an inflamed environment. After LPS treatment, EET reduced the protein levels of p-NF-κB (p65) in RAW264.7 cells 8 / 43 ( Fig 3A) . Moreover, high levels of the inflammatory cytokines in the supernatant (IL-1α, IL-6, IL-17A and MCP-1) secreted by LPS-activated RAW264.7 cells, were reduced after EET treatment ( Fig EV3, Fig 3B) . The supernatant from LPS-treated RAW264.7 cells significantly enhanced the proliferation viability of primary mouse hepatocytes, whereas decreases of the proliferation viability were shown when combination with EET ( Fig 3D) , suggesting that Cyp2c29 may suppress cell growth by attenuating inflammation.
We further investigate the role of Cyp2c29 under normal environment. The liver cell HL-7702 was transfected with a Cyp2c29 expression plasmid. qRT-PCR results confirmed Cyp2c29 expression ( Fig EV2) , and EET production analysis further verified it. Significantly enhanced 14,15-EET hydrolysate (14, levels were observed in the supernatant of the Cyp2c29-overexpressing HL-7702 cells ( Fig EV2C) . HL-7702 cells overexpressing Cyp2c29 or treated with exogenous EETs significantly enhanced cell proliferation viability than the control ( Fig 3C) , which could be blocked by the EET antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE) ( Fig 3C) . Our result was agreed with the report that EET enhanced cell proliferation in vitro (Boron& Boulpaep, 2002) . The data suggested that EET plays different roles in cell proliferation with or without inflammatory. Western blot analysis showed that expression of cyclin D1, a critical regulator of cell cycle progression and cell proliferation, was reduced in the EET and LPS co-treatment group, but caspase-3 expression was not significantly changed ( Fig 3E) . These data indicated that decreased proliferation might be the main cause of the suppressed 9 / 43 hepatocyte proliferation viability. Similar results were observed on hepatocellular carcinoma H22 cell line ( Fig EV4) .
Overexpression of Cyp2c29 reduced inflammation in liver injury models
NF-κB is a master regulator of inflammation and is also known to be a central signaling node between hepatic injury and HCC (Luedde & Schwabe, 2011) .
Consistent with previous reports, we found that the NF-κB signaling pathway was activated during liver inflammation based on data from DEN-induced HCC in mice ( Fig EV5) . To verify the role of Cyp2c29 in liver injury, we used two other liver injury models induced by acetaminophen (APAP) or carbon tetrachloride (CCl 4 ); these models are characterized by typical NF-κB activation and inflammatory responses (Tan et al, 2016; Jiang et al, 2017) . A Cyp2c29 expression plasmid was transfected into mice, and the mice were then injected with APAP or CCl 4 to induce liver injury. The animals were sacrificed at 6 h and 24 h after APAP administration.
Cyp2c29 expression both was increased on mRNA and protein levels in the APAP-treated group transfected with the Cyp2c29 plasmid ( Fig EV6) . During pathological examination, we found that the cell necrosis area was reduced in the Cyp2c29 group, as revealed by H&E staining of liver tissue ( Fig 4A-B ). Increased alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were observed in the APAP group treated with empty vector plasmid, whereas significantly decreased ALT and AST levels were detected in the Cyp2c29 group ( Fig 4C) ; these 10 / 43 results illustrated the protective effect of Cyp2c29 during liver injury. CCl 4 -treated mice also exhibited significantly lower Cyp2c29 expression than control mice ( Fig   EV6) , suggested that Cyp2c29 is consistently downregulated during liver injury. Less inflammatory infiltration and lower ALT levels were observed in the Cyp2c29 group (transfected with Cyp2c29 plasmid and treated with CCl 4 ) than in the CCl 4 model group ( Fig EV7A-D) . In addition, the number of CD68-positive cells in the liver was reduced in the Cyp2c29 group compared with the CCl 4 model group ( Fig EV7E) , which might attribute to decreased inflammatory infiltration and liver injury (McGuinness et al, 2000) .
Transcriptome analysis and in vivo experiments revealed a potential anti-inflammatory function of Cyp2c29 in liver injury
To further demonstrate the role of Cyp2c29 in liver injury, we performed RNA-seq to detect gene expression in APAP models treated with Cyp2c29 plasmid or empty vector plasmid for 6 h or 24 h.
We identified 131 upregulated and 261 downregulated DEGs at 6 h, and 81 upregulated and 254 downregulated DEGs at 24 h by comparing the Cyp2c29 treated group with the APAP model group ( Fig EV8) . Next, the specific functions of the DEGs were investigated ( Fig 5A) . The results indicated that compared with the control group (at 6 h and 24 h), the APAP model group showed suppressed metabolism and increased inflammation and cell death, while the opposite effects 11 / 43
were observed for the APAP group treated with Cyp2c29. Cell differentiation and programmed cell death pathways were highly active in the APAP model group but were all suppressed in the Cyp2c29-treated group. These effects were more significant at 24 h than at 6 h after treatment ( Fig 5A) . We further investigated the TF regulation of the genes in 10 significant pathways. Eleven TFs regulated genes associated with cell proliferation, inflammatory response and metabolism pathways were identified ( Fig 5B) . Furthermore, we explored the gene expression patterns of these pathways and found that liver tissues in the APAP model group exhibited high inflammatory activity and cell differentiation/death activity at 6 h and 24 h, while such activities were reduced in the Cyp2c29-treated group at 6 h and 24 h ( Fig 6A) . To further reveal the detailed mechanism, we mapped the DEGs between the Cyp2c29-treated group and APAP model group at 6 h to inflammation-related pathways, including the NF-κB, MAPK, TNF, and IL-17 pathways, and found that these pathways were all suppressed ( Fig EV9) .
Notably, we found that the expression of Cyp2c29 was inversely correlated with that of IL-1β, TNF, CCND1 and CCL2 ( Fig 6B) , which are marker genes on the NF-κB pathway (Taniguchi & Karin, 2018) . The protein levels of phosphorylated NF-κB p65 (also known as p-NF-kappaB p65 or p-NF-κB) were lower in the Cyp2c29 group than in the APAP model group ( Fig 6C) . An upstream regulator of NF-κB, IKK, was phosphorylated and activated in the APAP model group; however, Cyp2c29 overexpression reduced the phospho-IKK levels ( Fig 6C) . Therefore, Cyp2c29 suppressed the IKK-NF-κB signaling pathway. In the CCl 4 -induced mouse 12 / 43 model, decreased p-NF-κB was also observed in the Cyp2c29 group compared with the CCl 4 model group ( Fig EV7F) . These results indicated that the NF-κB pathway was suppressed in both the APAP-and CCl 4 -induced liver injury models after pre-treated with the Cyp2c29 plasmid. Immunohistochemical staining of Ki67 showed less liver cell proliferation in APAP-treated Cyp2c29-expressing mice than in APAP model mice ( Fig 6D) , indicating less compensatory regeneration during liver injury.
Consistent with these results, cyclin D1 was confirmed to be downregulated in the Cyp2c29 group ( Fig 6C) . protein sequence similarity, while CYP2C9 and Cyp2c29 share 89.0% similarity ( Fig   7A) . To explore the association between CYP epoxygenase expression and clinical outcomes in HCC patients, we performed an overall survival analysis using gene expression data from 363 HCC patients from the Cancer Genome Atlas (TCGA). The results indicated that high expression of CYP2C8 and CYP2C9 was positively correlated with clinical survival (significance: p = 0.046 and 0.0097, respectively) ( Fig 7B) . Next, we quantified the gene expression levels of CYP2C8 and CYP2C9 in 13 / 43 different HCC stages (TNM stages Ⅰ, Ⅱ, Ⅲ
Expression human homologous genes to mouse
, and Ⅳ) according to their clinical information ( Fig 7C) . The results showed that CYP2C8 and CYP2C9 expression significantly declined from stage I to stage III during HCC progression (Kruskal-Wallis, P < 0.001).
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Discussion
As one of the most lethal cancers worldwide, HCC, occurs in the context of chronic liver injury and inflammation (Bishayee, 2014) . Pathologic changes, including inflammatory infiltration, regeneration, fibrosis, and tumorous nodules, were observed in our DEN-induced mouse model, which are similar to changes associated with human HCC progression. Based on this model and time series gene expression analysis, we revealed Cyp2c29 as a key gene in the progression from liver injury to HCC and further characterized its function.
Cyp2c29 has been confirmed to be a specific CYP isoform responsible for EET-mediated vasodilator responses in mice (Sun et al, 2010) ; however, its role in HCC progression remains largely unknown. In our study, we found that the proliferation of primary hepatocytes was enhanced by supernatant from LPS-activated RAW264.7 cells, whereas the results were reversed by 14,15-EET, consistent with a previous report of the anti-inflammatory activity of 14,15-EET (Theken et al, 2011; Schmelzer et al, 2005; Oni-Orisan et al, 2013) . It has been reported that increases in EETs reduce vascular smooth muscle cell proliferation through downregulation of cyclin D1 (Davis et al, 2002) . Consistent with this report, our results showed that cyclin D1 expression was decreased while 14,15-EET was enhanced under conditions mimicking an inflammatory environment. Collectively, the production of EETs could be part of the reason why Cyp2c29 suppresses compensatory proliferation during liver injury.
The inflammatory reaction is commonly correlated with HCC progression.
15 / 43 (Karin & Lin, 2002; Iimuro et al, 1998) . Our results showed that the NF-κB pathway was activated in the DEN-treated mouse model. APAP-and CCl 4 -induced liver injury induced an acute inflammatory response that was not similar to the DEN-induced inflammation in our study. However, APAP-and CCl 4 -induced liver injury models are characterized by typical inflammatory responses and NF-κB pathway activation (Ruepp et al, 2002; Son et al, 2007) . Therefore, APAP-and CCl 4 -induced liver injury models were used to verify the role of Cyp2c29. In this study, mice transfected with the Cyp2c29 plasmid showed reduced injury and inflammation in both the APAP and CCl 4 models, suggesting a protective effect of Cyp2c29 against liver injury. When
Cyp2c29 was overexpressed, the levels of p-NF-κB and the expression of genes on NF-κB-related pathways, such as TNF and MAPK, which play important roles in inflammation and cell proliferation (Wagner & Nebreda, 2009; Grivennikov & Karin, 2011) , were downregulated. NF-κB is critical in the regulation of liver disease, influencing hepatocyte survival, Kupffer cell and hepatic stellate cell activation (Luedde & Schwabe, 2011) . NFκB activation is induced by infection, necrotic cell products, oxidative stress, and inflammatory cytokines such as TNF and IL-1 (Taniguchi & Karin, 2018) . Moreover, NF-κB activation leads to mediate the synthesis of proinflammatory cytokines (such as TNF, IL-1 and IL-6) and chemokines (such as CXCL1, CXCL2, and CCL2) (Tak & Firestein, 2001) . NF-κB and its related inflammatory molecules form a positive feedback loop and stimulate hepatocyte proliferation and liver regeneration, which may increase the risk of HCC. In this study, we found that Cyp2c29 overexpression significantly downregulate NF-κB signaling.
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We performed network analysis and illustrated the involvement of Cyp2c29 in signaling pathways ( Fig 7D) . Genes that encode inflammatory cytokines (such as TNF and IL-1), chemokines (such as CCL2, CXCL1, CXCL2, and CXCL3) and cell proliferation-related proteins (such as CycD and CycE) were downregulated when
Cyp2c29 was overexpressed in the mouse model of liver injury. These results demonstrate that Cyp2c29 may reduce liver injury through suppression of the inflammatory response.
High expression levels of CYP2C8 and CYP2C9, highly homologous to Cyc2C29, were found to be positively correlated with survival time in HCC patients.
Reduced expression levels of CYP2C8 and CYP2C9 were observed from stage I to stage III in HCC patients. However, another homologous gene CYP2J2 expression was not significantly associated with survival time in HCC patients from TCGA ( Fig   EV10) , although CYP2J2 expression has been reported to be associated with tumor progression (Jiang et al, 2005; Panigrahy et al, 2010) . This finding suggests that the role of CYP2J2 may vary in different cancers. These data together indicate the important roles of Cyp2c29 in liver injury and HCC progression.
In conclusion, Cyp2c29 was downregulated during liver injury in different mouse models. Cyp2c29 overexpression enhanced 14,15-EET production and suppressed inflammation-induced hepatocyte proliferation by inhibiting the IKK-NF-κB pathway during liver injury. Our data provide evidence that CYP2C epoxygenases could be potential therapeutic targets for liver diseases. Future studies investigating the effects of other epoxygenases in the CYP2C family may elucidate 17 / 43 additional regulators in HCC progression.
Materials and Protocols
Mice Four-week-old male C57BL/6 mice were purchased from the Hubei Research Province. All mice were treated with humane care. They were maintained in individual ventilated cages, given autoclaved water and fed irradiated food.
DEN-induced liver injury model
To mimic the process of HCC development, mice were orally administered diethylnitrosamine (DEN) (TCI， Japan) at a dose of 0.16 mmol·kg −1 body weight once a week for the first ten weeks and fed a high fat diet (HFD) for 30 weeks (Park et al, 2010; Bakiri &Wagner) . In the control group, mice were administered sesame oil (the solvent of DEN) once a week for the first ten weeks and fed a basal chow diet.
Separately at weeks 0, 10, 20, 25 and 30, mice were sacrificed, and liver tissues were collected for histological examination and RNA extraction.
Histological examination
Liver tissues were fixed in 4% formaldehyde for 24 h. Paraffin sections (5 μm) 18 / 43
were prepared for H&E staining for general morphological observation. Masson trichrome staining was used to reveal collagen fibers. The sections were observed using a light microscope (Nikon Eclipse TE2000-U) and then photographed at 100×, 200×, or 400× magnification. Liver histology scoring was performed as described previously (Hoque et al, 2012) .
Sequencing and identification of differentially expressed genes
High-throughput RNA-seq techniques were used to detect gene expression.
Three biological replicates for each group were sequenced. For RNA-seq, ribosomal RNA was first removed, and 150 bp paired-end sequencing was carried out on an Illumina HiSeq 3000 platform. All of the RNA isolation, sequencing and data filtering procedures were performed by RiboBio (Guangzhou, China). Assembly, alignment, quantification and profiling of the RNA-seq data were performed on our own server.
First, the quality of the reads was verified with FastQC (version: 0.11.3). Then, HISAT2 (version: 2.0.5) was used to map the sequencing reads to the mouse genome (GRCm38). Subsequently, StringTie (version: 1.2.2) was used to assemble the alignments into potential transcripts according to the reference sequences (Pertea et al, 2016) . Finally, transcript abundance was calculated as the FPKM. Additionally, NOISeq was used to identify DEGs with thresholds of a false discovery rate (FDR) < 0.01 and an |FC| ≥ 1.5. The data were submitted to BIG Data Center (http://bigd.big.ac.cn), and the assigned accession number of the submission is CRA000931. The rich factor in the bubble plots was calculated as the ratio of the number of genes that mapped to a certain pathway to the total number of genes in that pathway. Gene expression patterns were identified by hierarchical clustering and are displayed using a heat map. Furthermore, we investigated the most important pathways (Benjamini-Hochberg adjusted P < 0.05) and their crosstalk. For key gene selection, genes in the top-ranked pathways (P < 0.01) were deemed important. Then, we focused on the genes that were expressed in more than 80% of the groups. PLS-DA was employed to screen the important genes that contributed the most to differentiation of the groups. The cutoff was set as a VIP score >2.0 (the VIP score is a weighted sum of squares of the PLS loadings) (Xia et al, 2015) .
Selection of key genes and pathways
Cyp2c29 plasmid transfection
The Cyp2c29 pENTER-C-GFP plasmid and plasmid-harboring E. coli were supplied by Vigene Bioscience. The plasmid was sequenced to confirm its accuracy (GenBank accession number NM_007815.3). Then, plasmids were extracted and purified from E. coli with an EndoFree Plasmid Kit (Tiangen, China). Plasmids were transfected into HL-7702 cells according to the protocol of Lipofectamine ® 3000
Transfection Reagent (Thermo Fisher, USA). Hydrodynamics-based transfection of Cyp2c29 plasmids into mouse liver was performed as described previously (Liu et al, 20 / 43 1999) .
Treatment of HL-7702 cells with EET
The hepatocyte line HL-7702 was transfected with Cyp2c29 plasmid or treated with exogenous 11,12-EET or 14,15-EET (Cayman, USA) at a concentration of 100 nmol/L (Shen et al, 2008) . according to the manual.
Isolation of hepatocytes and non-parenchymal cells
Purification of primary hepatocytes was performed as described previously (Amaral et al, 2013) . Hepatocytes were separated with 90% Percoll solution RNA extraction and high-throughput sequencing were performed by BGI (Wuhan, China). Gene expression, DEGs and gene enrichment were analyzed by the same methods as those described above for the time series gene expression analysis. For the TF regulatory network analysis, we used the same method described in our previous publication . Finally, Cytoscape (version 3.2.1) was used to visualize the networks. The data were submitted to BIG Data Center 
Targeted proteomics
A quantitation of liver Cyp2c29 protein in mice after APAP and CCl 4 treatment was performed by targeted proteomics according to the previous reports (Kockmann et al, 2016 according to the ion signals in spectra library.
Survival analysis in human HCC
To verify the impact of Cyp2c29 homologous genes in humans, we investigated the effects of homologous gene expression on clinical survival. The homologous genes were obtained from HomoloGene (https://www.ncbi.nlm.nih.gov/homologene/), and their similarities and identities were calculated with Needle from EMBOSS (version: 6.6.0). The gene expression data of 363 patients with clinical survival information were downloaded from TCGA (Uhlén et al, 2015) . Kaplan-Meier analysis and log-rank tests were used for survival analysis as in GSCALite 
